Non-communicable diseases (NCDs) are the leading causes
Introduction
Non-communicable diseases (NCDs) are the leading causes of morbidity and account for 70% of worldwide deaths, with the major burden felt in low-and middle-income countries (LMICs) 1 . The problem is highlighted in the UN Sustainable Development Goals (SDGs), with SDG target 3.4 aiming to reduce premature mortality from NCDs by one-third between 2015 and 2030 2 . Progress is slow with poor health system responsiveness and weak monitoring capacity being important obstacles 3 .
In 2014-2015, Sierra Leone was hit by a devastating Ebola virus disease outbreak that highlighted the need for resilient health systems 4, 5 . At that time, diagnosis, care and management of NCDs were in the process of decentralization from hospital to primary healthcare settings. In 2017, we reported on the burden and distributions of selected NCDs in a sample of health facilities in the Western-Area District, Sierra Leone, before and during the Ebola outbreak 6 . There was a marked decline in reported NCD numbers in the Ebola compared with the preEbola periods, and this was especially observed for hypertension (HTN) and diabetes mellitus (DM) and in secondary and tertiary hospitals compared with peripheral health units (PHUs). Several recommendations were made that included strengthening the diagnosis, management and monitoring of NCDs in all district health facilities.
We now have comprehensive reports from all the district facilities for six-month periods before Ebola (June-December 2013), during Ebola (June-December 2014) and post-Ebola (JuneDecember 2015) and have taken the opportunity to assess what has happened to NCDs during this time. The study objectives were to assess reported NCD numbers, the distribution of NCDs and their stratification by health facility level in the Western-Area District in the post-Ebola period and compare findings with Ebola and pre-Ebola periods outlined abov
Methods

Data source
This was a cross-sectional study using secondary data from routine records. The setting and district monitoring system have been previously described 6 . In the current study, however, all public health facilities in the Western-Area District, Sierra Leone, were included: 110 PHUs, 9 secondary and 4 tertiary hospitals. The study population included all people reported with cardiovascular disease (CVD), HTN, DM, mental health disorder (MHD) and tumours/cancer in June-December 2013, June-December 2014 and June-December 2015. Data sources were the aggregate monthly NCD reports available at the Directorate of Policy, Planning and Information, Ministry of Health and Sanitation.
Data analysis
Data were analysed using Open EPI version 3.03 (updated 2014/09/22), with comparisons made between the post-Ebola and pre-Ebola/Ebola periods using the chi square test. P<0.05 was considered to indicate a significant difference.
Ethical approval
Ethics approval was obtained from the Sierra Leone Ethics and Scientific Committee (dated 14 December 2018) and the Ethics Advisory Group, International Union Against Tuberculosis and Lung Disease, Paris, France (EAG number 63/18). As aggregate data were used with no identifiers, the need for informed consent was waived by the ethics committees.
Results
Altogether there were 10,011 people reported with NCDs during the three six-month periods, of whom 6194 (62%) were at PHU, 720 (7%) at secondary and 3097 (31%) at tertiary hospitals. Numbers with the five selected NCDs in the three different time periods are shown in Table 1 . Key findings were: i) a decrease followed by an increase in NCDs in Ebola and post-Ebola periods with numbers not reaching pre-Ebola levels and this distribution was mirrored for HTN; ii) a large increase in DM in the post-Ebola period; iii) a decrease in CVD and tumours/cancer in the Ebola outbreak which continued to decline or stay unchanged in the post-Ebola period; and iv) small numbers of MHD in all three periods. These changes between the different periods were similar for males and females.
NCD distributions in the three health facility levels are shown in Table 2 . Key findings were: i) 72% of reported HTN and 94% of reported MHD cases were at PHU, while 83% of reported CVD, 64% of reported DM and 94% of reported tumour/cancer cases were at tertiary hospitals; ii) the proportion of reported HTN cases was maintained over the three six-month periods at PHU in contrast to the hospital settings; iii) numbers with DM generally stayed the same except for a significant post-Ebola increase in tertiary hospitals; iv) those with CVD decreased significantly in the post-Ebola period in PHU and tertiary hospitals.
Discussion
The three most common NCDs during the study period were HTN, DM and CVD, with DM assuming greater importance in The chi-square test was used to compare results of categorical variables in the postEbola period with the pre-Ebola and Ebola periods: *P< 0.05; **P<0.001 the post-Ebola period. Reasons are unclear, although DM has been predicted to increase dramatically in the next 10-20 years throughout sub-Saharan Africa 7 . In all three six-month periods it was encouraging to see that HTN was predominately managed at the PHU as opposed to hospitals, suggesting that the process of decentralisation in this area is well underway. The management of DM could benefit from the same approach. The small number of individuals reported with MHD is of concern, especially given the high prevalence of anxiety, depression and post-traumatic stress disorder following the Ebola outbreak 8 .
The strengths of the study are the inclusion of all public health facilities, making this study representative of the district. Limitations include use of routine aggregate data (the accuracy of which could not be verified), the lack of data from the private sector and missing hospital data for 2016 and 2017, which prevented further assessment of the post-Ebola recovery period.
There are important policy recommendations from this study. It is clear that the majority of NCDs in the district are managed at the PHU; this move for decentralisation is in line with Sierra Leone's 2017-2021 National Health Sector Strategic Plan 9
. To ensure quality of care, however, the availability of medicines, diagnostic tools, a trained workforce, use of standardised NCD protocols and robust information systems must also be decentralised 10 . Health facility reporting forms and processes must also be reassessed to improve consistency of case definitions and ensure complete and accurate records, without which resource management to strengthen NCD care is not possible.
In conclusion, this study shows that NCD reporting is recovering in the immediate post-Ebola period. Decentralisation could be an effective and resilient strategy for management as evidenced by HTN. This encouraging momentum must be accompanied by health system strengthening-particularly for information systems-which will help move the country to universal health coverage and achievement of SDG3.4.
Data availability
Open Science Framework: Kamara_IbrahimK_SORTIT2_NCD_ data 2019. https://doi.org/10.17605/OSF. IO/5Q3AX 11 . This project contains the number of cases of each disease for each time period, alongside a data dictionary.
The Sierra Leone Health Management Information Systems, the District Health Information System 2 (DHIS2), is accessible with a Ministry of Health and Sanitation login through https://sl.dhis2.org/. The Directorate of Policy, Planning, and Information (DPPI) can be contacted through Dr. Francis Smart (drfsmart@gmail.com), Director, DPPI, MOHS, with an information request detailing the specific data request and purpose of use. Applicants will be asked to provide details of the reason for the request and details pertaining data request (such as data points, disaggregation, time period). In this case, data access wolud be granted to persons who request data for research purposes if they can provide appropriate ethical approval documentation. Reviewer Expertise: Public health, NCDs, Ebola, HIV/TB, infectious diseases I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.
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